首页> 外文期刊>Trends in Biotechnology >Acheiving compliance for biologics
【24h】

Acheiving compliance for biologics

机译:实现生物制剂的合规性

获取原文
获取原文并翻译 | 示例
       

摘要

The Validation of Biotech Manufacturing to Achieve Compliance conference was Organized by Vision In Business and was Held 30 and 31 January 2001 in Brussels, Belgium. The manufacture of biologics (protein Therapeutics) and associated topics have Become popular subjects for conferences during the past few years. This has arisen Partly owing to the greater awareness of The domain and the increasing number of Products in this category but also Because, with this diverse subject, there Are real problems to overcome. Biologies Cover a range of biologically derived Medical products, often referred to as 'biotech products', and include blood derivatives, vaccines, recombinant proteins and gene therapy vectors.
机译:Vision In Business组织了“通过生物技术制造实现合规性验证”会议,该会议于2001年1月30日至31日在比利时布鲁塞尔举行。在过去几年中,生物制剂(蛋白质治疗剂)及其相关主题的生产已成为会议的热门话题。之所以出现这种情况,部分原因是由于对该领域的意识增强,并且该类别产品的数量不断增加,而且还因为在这个多样化的主题中,有一些实际问题需要克服。生物学涵盖了一系列生物衍生的医疗产品,通常被称为“生物技术产品”,包括血液衍生物,疫苗,重组蛋白和基因治疗载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号